Toward the benefit and value of immune treatment beyond progression in lung cancer? Insights from a systematic review and meta-analysis
ObjectiveImmune treatment beyond progression (ITBP) has emerged as a novel therapeutic strategy in oncology. This systematic review and meta-analysis aim to evaluate the efficacy and safety of ITBP in patients with lung cancer, while also identifying c…